US Stock MarketDetailed Quotes

ELVN Enliven Therapeutics

Watchlist
  • 23.150
  • +0.150+0.65%
Close Dec 13 16:00 ET
  • 23.150
  • 0.0000.00%
Post 16:00 ET
1.13BMarket Cap-12.84P/E (TTM)

Enliven Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
23.29%-12.19M
-69.60%-20.44M
-12.08%-23.36M
-91.01%-61.27M
-53.25%-12.48M
-146.53%-15.89M
-69.13%-12.05M
-101.18%-20.84M
-67.64%-32.08M
-23.52%-8.15M
Net income from continuing operations
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
-52.23%-37.66M
-13.80%-9.55M
Depreciation and amortization
2.56%80K
5.41%78K
17.91%79K
38.14%297K
21.88%78K
30.00%78K
42.31%74K
71.79%67K
86.96%215K
93.94%64K
Other non cash items
--7K
---720K
--79K
--306K
--78K
----
----
----
----
----
Change In working capital
58.25%4.99M
-455.27%-4.38M
45.14%-4.64M
219.86%1.4M
801.65%5.46M
161.58%3.15M
21.94%1.23M
-254.26%-8.45M
-87.72%438K
-47.21%606K
-Change in prepaid assets
132.34%783K
-850.00%-2.45M
40.18%-3.64M
-132.89%-3.7M
2,365.79%1.72M
162.18%337K
175.81%326K
-1,023.25%-6.09M
-182.42%-1.59M
82.49%-76K
-Change in payables and accrued expense
40.90%4.29M
-304.18%-1.86M
61.44%-910K
167.49%5.41M
461.09%3.82M
74.44%3.04M
-36.92%909K
-28.05%-2.36M
-49.36%2.02M
-55.95%681K
-Change in other current liabilities
63.32%-84K
-8,200.00%-83K
-8,200.00%-83K
-7,850.00%-310K
-8,000.00%-79K
---229K
---1K
---1K
--4K
--1K
Cash from discontinued investing activities
Operating cash flow
23.29%-12.19M
-69.60%-20.44M
-12.08%-23.36M
-91.01%-61.27M
-53.25%-12.48M
-146.53%-15.89M
-69.13%-12.05M
-101.18%-20.84M
-67.64%-32.08M
-23.52%-8.15M
Investing cash flow
Cash flow from continuing investing activities
141.71%14.83M
77.78%-33.67M
-57,593.55%-17.89M
-24,150.33%-148.41M
38,402.97%38.69M
-253,821.43%-35.55M
-49,905.94%-151.52M
84.02%-31K
-220.42%-612K
-77.19%-101K
Net PPE purchase and sale
-37.50%-22K
97.73%-2K
35.48%-20K
75.65%-149K
86.14%-14K
-14.29%-16K
70.96%-88K
84.02%-31K
-220.42%-612K
-77.19%-101K
Net investment purchase and sale
167.47%23.98M
71.17%-43.66M
---17.87M
---148.26M
--38.7M
---35.53M
---151.43M
--0
--0
--0
Net other investing changes
---9.13M
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
141.71%14.83M
77.78%-33.67M
-57,593.55%-17.89M
-24,150.33%-148.41M
38,402.97%38.69M
-253,821.43%-35.55M
-49,905.94%-151.52M
84.02%-31K
-220.42%-612K
-77.19%-101K
Financing cash flow
Cash flow from continuing financing activities
362.82%1.12M
164.04%1.81M
-61.98%90.27M
13,123.12%234.29M
103.79%90K
-359.15%-425K
-56,500.00%-2.82M
57,954.03%237.44M
-77.07%-1.8M
-60.93%-2.38M
Net common stock issuance
--0
---305K
--90M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
3,889.29%1.12M
1,397.16%2.11M
92.86%270K
-32.49%399K
592.31%90K
--28K
2,720.00%141K
-75.57%140K
--591K
--13K
Net other financing activities
----
----
----
9,886.07%233.89M
--0
---453K
---2.96M
144,795.73%237.3M
-61.49%-2.39M
----
Cash from discontinued financing activities
Financing cash flow
362.82%1.12M
164.04%1.81M
-61.98%90.27M
13,123.12%234.29M
103.79%90K
-359.15%-425K
-56,500.00%-2.82M
57,954.03%237.44M
-77.07%-1.8M
-60.93%-2.38M
Net cash flow
Beginning cash position
-22.93%96.93M
-48.92%149.22M
32.55%100.2M
-31.33%75.59M
-14.28%73.9M
35.95%125.77M
192.35%292.16M
-31.33%75.59M
-15.60%110.08M
-27.07%86.21M
Current changes in cash
107.23%3.75M
68.57%-52.29M
-77.36%49.02M
171.34%24.61M
347.52%26.29M
-723.69%-51.87M
-2,141.81%-166.39M
2,234.50%216.57M
-69.55%-34.49M
-30.70%-10.62M
End cash Position
36.23%100.68M
-22.93%96.93M
-48.92%149.22M
32.55%100.2M
32.55%100.2M
-14.28%73.9M
35.95%125.77M
192.35%292.16M
-31.33%75.59M
-31.33%75.59M
Free cash flow
23.22%-12.22M
-68.39%-20.44M
-12.00%-23.38M
-87.89%-61.42M
-51.54%-12.5M
-146.25%-15.91M
-63.42%-12.14M
-97.77%-20.88M
-69.15%-32.69M
-23.98%-8.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 23.29%-12.19M-69.60%-20.44M-12.08%-23.36M-91.01%-61.27M-53.25%-12.48M-146.53%-15.89M-69.13%-12.05M-101.18%-20.84M-67.64%-32.08M-23.52%-8.15M
Net income from continuing operations -11.49%-23.16M-19.31%-19.95M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M-52.23%-37.66M-13.80%-9.55M
Depreciation and amortization 2.56%80K5.41%78K17.91%79K38.14%297K21.88%78K30.00%78K42.31%74K71.79%67K86.96%215K93.94%64K
Other non cash items --7K---720K--79K--306K--78K--------------------
Change In working capital 58.25%4.99M-455.27%-4.38M45.14%-4.64M219.86%1.4M801.65%5.46M161.58%3.15M21.94%1.23M-254.26%-8.45M-87.72%438K-47.21%606K
-Change in prepaid assets 132.34%783K-850.00%-2.45M40.18%-3.64M-132.89%-3.7M2,365.79%1.72M162.18%337K175.81%326K-1,023.25%-6.09M-182.42%-1.59M82.49%-76K
-Change in payables and accrued expense 40.90%4.29M-304.18%-1.86M61.44%-910K167.49%5.41M461.09%3.82M74.44%3.04M-36.92%909K-28.05%-2.36M-49.36%2.02M-55.95%681K
-Change in other current liabilities 63.32%-84K-8,200.00%-83K-8,200.00%-83K-7,850.00%-310K-8,000.00%-79K---229K---1K---1K--4K--1K
Cash from discontinued investing activities
Operating cash flow 23.29%-12.19M-69.60%-20.44M-12.08%-23.36M-91.01%-61.27M-53.25%-12.48M-146.53%-15.89M-69.13%-12.05M-101.18%-20.84M-67.64%-32.08M-23.52%-8.15M
Investing cash flow
Cash flow from continuing investing activities 141.71%14.83M77.78%-33.67M-57,593.55%-17.89M-24,150.33%-148.41M38,402.97%38.69M-253,821.43%-35.55M-49,905.94%-151.52M84.02%-31K-220.42%-612K-77.19%-101K
Net PPE purchase and sale -37.50%-22K97.73%-2K35.48%-20K75.65%-149K86.14%-14K-14.29%-16K70.96%-88K84.02%-31K-220.42%-612K-77.19%-101K
Net investment purchase and sale 167.47%23.98M71.17%-43.66M---17.87M---148.26M--38.7M---35.53M---151.43M--0--0--0
Net other investing changes ---9.13M------------------------------------
Cash from discontinued investing activities
Investing cash flow 141.71%14.83M77.78%-33.67M-57,593.55%-17.89M-24,150.33%-148.41M38,402.97%38.69M-253,821.43%-35.55M-49,905.94%-151.52M84.02%-31K-220.42%-612K-77.19%-101K
Financing cash flow
Cash flow from continuing financing activities 362.82%1.12M164.04%1.81M-61.98%90.27M13,123.12%234.29M103.79%90K-359.15%-425K-56,500.00%-2.82M57,954.03%237.44M-77.07%-1.8M-60.93%-2.38M
Net common stock issuance --0---305K--90M----------0--0--0--------
Proceeds from stock option exercised by employees 3,889.29%1.12M1,397.16%2.11M92.86%270K-32.49%399K592.31%90K--28K2,720.00%141K-75.57%140K--591K--13K
Net other financing activities ------------9,886.07%233.89M--0---453K---2.96M144,795.73%237.3M-61.49%-2.39M----
Cash from discontinued financing activities
Financing cash flow 362.82%1.12M164.04%1.81M-61.98%90.27M13,123.12%234.29M103.79%90K-359.15%-425K-56,500.00%-2.82M57,954.03%237.44M-77.07%-1.8M-60.93%-2.38M
Net cash flow
Beginning cash position -22.93%96.93M-48.92%149.22M32.55%100.2M-31.33%75.59M-14.28%73.9M35.95%125.77M192.35%292.16M-31.33%75.59M-15.60%110.08M-27.07%86.21M
Current changes in cash 107.23%3.75M68.57%-52.29M-77.36%49.02M171.34%24.61M347.52%26.29M-723.69%-51.87M-2,141.81%-166.39M2,234.50%216.57M-69.55%-34.49M-30.70%-10.62M
End cash Position 36.23%100.68M-22.93%96.93M-48.92%149.22M32.55%100.2M32.55%100.2M-14.28%73.9M35.95%125.77M192.35%292.16M-31.33%75.59M-31.33%75.59M
Free cash flow 23.22%-12.22M-68.39%-20.44M-12.00%-23.38M-87.89%-61.42M-51.54%-12.5M-146.25%-15.91M-63.42%-12.14M-97.77%-20.88M-69.15%-32.69M-23.98%-8.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List